Novo Nordisk | Eigenkapital Und Reserven



Equity Capital And Reserves Veränderung Datum
ANI Pharmaceuticals USD 403.68M 2.27M 2024-12
Aurora Cannabis CAD 572.92M 29.75M 2024-12
Bausch Health Companies USD -1174000000 947M 2024-09
Bristol-Myers Squibb USD 16.34B 807M 2024-12
Canopy Growth CAD 591.48M 81.81M 2024-12
Corcept Therapeutics USD 679.59M 40.75M 2024-12
Drreddys Laboratories INR 317.72B 12.38B 2024-12
Eli Lilly USD 14.19B 47.9M 2024-12
GlaxoSmithKline GBP 13.67B 218M 2024-12
Merck USD 46.31B 1.81B 2024-12
Novartis USD 44.05B 605M 2024-12
Novo Nordisk 120.52B 8B 2024-09
Novo Nordisk DKK 120.52B 8B 2024-09
Pacira USD 778.35M 28.76M 2024-12
Perrigo USD 4.32B 246.6M 2024-12
Prestige Brands USD 1.79B 56.67M 2024-12
Sanofi 73B 1.36B 2024-06
Supernus Pharmaceuticals USD 1.04B 28.58M 2024-12
Zoetis USD 4.77B 464M 2024-12



Novo Nordisk Eigenkapital Und Reserven - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.